Predictive Oncology issues Series F Preferred Stock dividend to secure reverse split votes

Axe Compute Inc.

Board declared dividend of 1/1000th of a share of Series F Preferred for each common share, payable March 27, 2023.
Series F Preferred has 1,000 votes per share (1,000 votes per 1/1000th share) but only votes on reverse stock split.
Shares are non-transferable except with common; all not present at reverse split meeting will be automatically redeemed.
Redemption consideration is $0.10 per ten shares; shares also redeemable upon Board order or stockholder approval of reverse split.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Axe Compute Inc.: Board of Directors declared a dividend of Series F Preferred Stock and established its terms, including voting rights, transferability, dividend rights, liquidation preference, and redemption provisions (effective 2023-03-16).

Change: bylaw amendment
Effective: 2023-03-16

Exact text from the filing

On March 16, 2023, the board of directors (the “Board” ) of Predictive Oncology Inc. (the “Company” ) declared a dividend of one one-thousandth of a share of Series F Preferred Stock, par value $0.01 per share ( “Series F Preferred Stock” ), for each outstanding share of the Company’s common stock, par value $0.01 per share ( “Common Stock” ) to stockholders of record at 5:00 p.m. Eastern Time on March 27, 2023 (the “Record Date” ).

View on SEC.gov

37 governance changes filed in the last 30 days. Browse all governance changes →

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-001737

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.